retatrutide safety clinical trial Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 How To Get Retatrutide with

GLP-1 receptor agonists including Ozempic, Wegovy, Mounjaro, and Rybelsus are now among the most widely prescribed medications for diabetes and rapid weight loss

( ) DSIP ,

HOFFMANN-LA ROCHE LTD

These future developments are fundamentally different from current commercial GLP-1 patches and would require rigorous clinical trials and regulatory approval before becoming available

Generally, GLP-1 medications can be restarted when: The patient has fully recovered from anaesthesia Normal gastrointestinal function has returned The patient can tolerate regular oral intake without significant nausea or vomiting Any post-operative complications have resolved Patients should always consult their healthcare team before restarting these medications